(Q51122607)

30 March 2018

title

Improved screening for cystic fibrosis-related diabetes by an integrated care team using an algorithm. (English)

1 reference

30 March 2018

0 references

Maria Socorro Rayas

1

1 reference

30 March 2018

Donna Beth Willey-Courand

series ordinal

2

1 reference

30 March 2018

Jane Lockwood Lynch

series ordinal

3

1 reference

30 March 2018

Jesus Ramon Guajardo

series ordinal

4

1 reference

30 March 2018

publication date

16 January 2014

1 reference

30 March 2018

published in

Pediatric Pulmonology

1 reference

30 March 2018

volume

49

1 reference

30 March 2018

issue

10

1 reference

30 March 2018

page(s)

971-977

1 reference

30 March 2018

Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Microvascular complications in cystic fibrosis-related diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Long-term effect of insulin treatment in cystic fibrosis-related diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Cystic fibrosis: terminology and diagnostic algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Screening for cystic fibrosis-related diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22988

21 January 2018

Identifiers

DOI

10.1002/PPUL.22988

1 reference

30 March 2018

1 reference

30 March 2018